- Home
- TNXP vs OZ Comparison
TNXP vs OZ Comparison
Compare TNXP & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- OZ
- Stock Information
- Founded
- TNXP 2007
- OZ 2020
- Country
- TNXP United States
- OZ United States
- Employees
- TNXP N/A
- OZ N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- TNXP Health Care
- OZ
- Exchange
- TNXP Nasdaq
- OZ Nasdaq
- Market Cap
- TNXP 207.5M
- OZ 236.3M
- IPO Year
- TNXP N/A
- OZ N/A
- Fundamental
- Price
- TNXP $39.78
- OZ $65.07
- Analyst Decision
- TNXP Strong Buy
- OZ
- Analyst Count
- TNXP 2
- OZ 0
- Target Price
- TNXP $585.00
- OZ N/A
- AVG Volume (30 Days)
- TNXP 1.3M
- OZ 2.8K
- Earning Date
- TNXP 05-12-2025
- OZ 01-01-0001
- Dividend Yield
- TNXP N/A
- OZ N/A
- EPS Growth
- TNXP N/A
- OZ N/A
- EPS
- TNXP N/A
- OZ N/A
- Revenue
- TNXP $10,041,000.00
- OZ $4,077,000.00
- Revenue This Year
- TNXP $12.17
- OZ N/A
- Revenue Next Year
- TNXP $789.15
- OZ N/A
- P/E Ratio
- TNXP N/A
- OZ N/A
- Revenue Growth
- TNXP N/A
- OZ 94.70
- 52 Week Low
- TNXP $6.76
- OZ $56.77
- 52 Week High
- TNXP $558.08
- OZ $82.89
- Technical
- Relative Strength Index (RSI)
- TNXP 74.56
- OZ 53.10
- Support Level
- TNXP $25.40
- OZ $63.25
- Resistance Level
- TNXP $37.84
- OZ $65.51
- Average True Range (ATR)
- TNXP 4.17
- OZ 0.91
- MACD
- TNXP 1.75
- OZ -0.07
- Stochastic Oscillator
- TNXP 87.00
- OZ 51.33
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.